Europe

First U.S. Patient Enrolled in PRESERVE CAP Study for XVIVO Heart Assist Transport System

Pivotal trial launches to evaluate XVIVO’s portable perfusion device designed to optimize heart preservation and transplantation outcomes across the U.S....

UroMems Secures FDA and ANSM Clearance to Begin Pivotal Study of UroActive® Smart Implant for Male SUI

Landmark trial to evaluate world’s first autonomous, electronic artificial urinary sphincter for stress urinary incontinence in men...

Digostics Launches University Trial for At-home Type 1 Diabetes Test

Pioneering Study Aims to Validate Convenient, Early Detection Method for Type 1 Diabetes Outside Clinical Settings...

Safe Life Expands Global Footprint with Acquisition of HTM Medico in Singapore

Strategic Move Marks Safe Life’s Entry into the Asian Market, Strengthening Its Position in Health Technology Management Across the Region...

Erbe Launches FiAPC® plus to Elevate Argon Plasma Coagulation Precision

Next-Generation Technology Enhances Control, Safety, and Efficiency in Flexible Endoscopic Procedures ...

Companion Spine to Acquire Paradigm Spine GmbH and Coflex®, CoFix® Implant Assets from Xtant Medical

Strategic Acquisition Expands Companion Spine’s Portfolio in Motion-Preserving, Minimally Invasive Spine Therapies...

Alcon to Acquire LumiThera, Expanding Retinal Portfolio with Breakthrough AMD Therapy

Acquisition adds FDA-cleared Valeda® Light Delivery System to Alcon’s pipeline, targeting early and intermediate dry age-related macular degeneration through photobiomodulation technology ...

Major U.S. Healthcare System Expands Sectra Partnership to Include Pathology Imaging

Enterprise Imaging Cloud Now Integrates Pathology for Streamlined Cancer Diagnostics and Cross-Disciplinary Collaboration ...

ONWARD Medical Appoints Neurotechnology Expert Tim Denison, PhD to Board of Directors

Renowned entrepreneur and academic leader brings deep expertise in neuroscience, bioelectronics, and medtech innovation to support ONWARD’s mission in restoring mobility and function through neuromodulation....

Median Technologies Advances AI-Powered Lung Cancer Screening with CE Mark Filing for eyonis® LCS

Regulatory submission for Class IIb CE Mark and ISO 13485 certification paves the way for European launch of Median’s AI-driven SaMD platform targeting early lung cancer detection....